Knockdown of NRF2 and NRF2-targeted genes, glucose-6-phosphate dehydrogenase, and phosphoglycerate dehydrogenase, promotes erastin- or sorafenib-induced ferroptosis in hepatocellular carcinoma cells. Here, NFE2L2 is linked to hepatocellular carcinoma.